Literature DB >> 33128848

BMI as a Risk Factor for Clinical Outcomes in Patients Hospitalized with COVID-19 in New York.

Tara S Kim1,2, Mitchell Roslin3, Jason J Wang2, Jamie Kane1, Jamie S Hirsch2,4, Eun Ji Kim1,2.   

Abstract

OBJECTIVE: This study examined the association between BMI and clinical outcomes among patients with coronavirus disease 2019 (COVID-19) infection.
METHODS: A total of 10,861 patients with COVID-19 infection who were admitted to the Northwell Health system hospitals between March 1, 2020, and April 27, 2020, were included in this study. BMI was classified as underweight, normal weight, overweight, and obesity classes I, II, and III. Primary outcomes were invasive mechanical ventilation (IMV) and death.
RESULTS: A total of 243 (2.2%) patients were underweight, 2,507 (23.1%) were normal weight, 4,021 (37.0%) had overweight, 2,345 (21.6%) had obesity class I, 990 (9.1%) had obesity class II, and 755 (7.0%) had obesity class III. Patients who had overweight (odds ratio [OR] = 1.27 [95% CI: 1.11-1.46]), obesity class I (OR = 1.48 [95% CI: 1.27-1.72]), obesity class II (OR = 1.89 [95% CI: 1.56-2.28]), and obesity class III (OR = 2.31 [95% CI: 1.88-2.85]) had an increased risk of requiring IMV. Underweight and obesity classes II and III were statistically associated with death (OR = 1.44 [95% CI: 1.08-1.92]; OR = 1.25 [95% CI: 1.03-1.52]; OR = 1.61 [95% CI: 1.30-2.00], respectively). Among patients who were on IMV, BMI was not associated with inpatient deaths.
CONCLUSIONS: Patients who are underweight or who have obesity are at risk for mechanical ventilation and death, suggesting that pulmonary complications (indicated by IMV) are a significant contributor for poor outcomes in COVID-19 infection.
© 2020 The Obesity Society.

Entities:  

Mesh:

Year:  2020        PMID: 33128848      PMCID: PMC8191573          DOI: 10.1002/oby.23076

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  16 in total

1.  Methods for using data abstracted from medical charts to impute longitudinal missing data in a clinical trial.

Authors:  Paul L Hebert; Leslie T Taylor; Jason J Wang; Margo A Bergman
Journal:  Value Health       Date:  2011-10-12       Impact factor: 5.725

2.  Body mass index is associated with the development of acute respiratory distress syndrome.

Authors:  M N Gong; E K Bajwa; B T Thompson; D C Christiani
Journal:  Thorax       Date:  2009-09-21       Impact factor: 9.139

3.  Underweight, overweight and obesity as risk factors for mortality and hospitalization.

Authors:  Gunilla Ringbäck Weitoft; Mats Eliasson; Måns Rosén
Journal:  Scand J Public Health       Date:  2008-03       Impact factor: 3.021

4.  COVID-19 and the role of chronic inflammation in patients with obesity.

Authors:  Sonja Chiappetta; Arya M Sharma; Vincenzo Bottino; Christine Stier
Journal:  Int J Obes (Lond)       Date:  2020-05-14       Impact factor: 5.095

5.  Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality.

Authors:  Mark R Geier; David A Geier
Journal:  Med Hypotheses       Date:  2020-04-22       Impact factor: 1.538

6.  COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options.

Authors:  Tomasz J Guzik; Saidi A Mohiddin; Anthony Dimarco; Vimal Patel; Kostas Savvatis; Federica M Marelli-Berg; Meena S Madhur; Maciej Tomaszewski; Pasquale Maffia; Fulvio D'Acquisto; Stuart A Nicklin; Ali J Marian; Ryszard Nosalski; Eleanor C Murray; Bartlomiej Guzik; Colin Berry; Rhian M Touyz; Reinhold Kreutz; Dao Wen Wang; David Bhella; Orlando Sagliocco; Filippo Crea; Emma C Thomson; Iain B McInnes
Journal:  Cardiovasc Res       Date:  2020-08-01       Impact factor: 10.787

7.  Risk of COVID-19 for patients with obesity.

Authors:  Radwan Kassir
Journal:  Obes Rev       Date:  2020-04-13       Impact factor: 9.213

Review 8.  Obesity ‑ a risk factor for increased COVID‑19 prevalence, severity and lethality (Review).

Authors:  Demetrios Petrakis; Denisa Margină; Konstantinos Tsarouhas; Fotios Tekos; Miriana Stan; Dragana Nikitovic; Demetrios Kouretas; Demetrios A Spandidos; Aristidis Tsatsakis
Journal:  Mol Med Rep       Date:  2020-05-05       Impact factor: 2.952

9.  Kidney disease is associated with in-hospital death of patients with COVID-19.

Authors:  Yichun Cheng; Ran Luo; Kun Wang; Meng Zhang; Zhixiang Wang; Lei Dong; Junhua Li; Ying Yao; Shuwang Ge; Gang Xu
Journal:  Kidney Int       Date:  2020-03-20       Impact factor: 10.612

10.  High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation.

Authors:  Arthur Simonnet; Mikael Chetboun; Julien Poissy; Violeta Raverdy; Jerome Noulette; Alain Duhamel; Julien Labreuche; Daniel Mathieu; Francois Pattou; Merce Jourdain
Journal:  Obesity (Silver Spring)       Date:  2020-06-10       Impact factor: 9.298

View more
  29 in total

1.  Association of Obesity With COVID-19 Severity and Mortality: An Updated Systemic Review, Meta-Analysis, and Meta-Regression.

Authors:  Romil Singh; Sawai Singh Rathore; Hira Khan; Smruti Karale; Yogesh Chawla; Kinza Iqbal; Abhishek Bhurwal; Aysun Tekin; Nirpeksh Jain; Ishita Mehra; Sohini Anand; Sanjana Reddy; Nikhil Sharma; Guneet Singh Sidhu; Anastasios Panagopoulos; Vishwanath Pattan; Rahul Kashyap; Vikas Bansal
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-03       Impact factor: 6.055

Review 2.  Diabetes and SARS-CoV-2-Is There a Mutual Connection?

Authors:  Anna P Jedrzejak; Edyta K Urbaniak; Jadwiga A Wasko; Natalia Ziojla; Malgorzata Borowiak
Journal:  Front Cell Dev Biol       Date:  2022-06-13

Review 3.  Obesity Impact on SARS-CoV-2 Infection: Pros and Cons "Obesity Paradox"-A Systematic Review.

Authors:  Damiana-Maria Vulturar; Carmen-Bianca Crivii; Olga Hilda Orăsan; Emanuel Palade; Anca-Dana Buzoianu; Iulia Georgiana Zehan; Doina Adina Todea
Journal:  J Clin Med       Date:  2022-07-02       Impact factor: 4.964

4.  Inflammation, underweight, malignancy and a marked catabolic state as predictors for worse outcomes in COVID-19 patients with moderate-to-severe disease admitted to Internal Medicine Unit.

Authors:  Valeria Guglielmi; Luca Colangeli; Valeria Scipione; Simona Ballacci; Martina Di Stefano; Lauren Hauser; Michela Colella Bisogno; Monica D'Adamo; Emanuela Medda; Paolo Sbraccia
Journal:  PLoS One       Date:  2022-05-18       Impact factor: 3.752

5.  Reduction in Long-term Mortality after Sleeve Gastrectomy and Gastric Bypass Compared to Non-surgical Patients with Severe Obesity.

Authors:  Anita P Courcoulas; Eric Johnson; David E Arterburn; Sebastien Haneuse; Lisa J Herrinton; David P Fisher; Robert A Li; Mary Kay Theis; Liyan Liu; Brianna Taylor; Julie Cooper; Philip L Chin; Gary G Grinberg; Anirban Gupta; Shireesh Saurabh; Scott S Um; Panduranga R Yenumula; Jorge L Zelada; Karen J Coleman
Journal:  Ann Surg       Date:  2021-08-13       Impact factor: 12.969

Review 6.  The Weight of Obesity in Immunity from Influenza to COVID-19.

Authors:  Fernanda B Andrade; Ana Gualberto; Camila Rezende; Nathércia Percegoni; Jacy Gameiro; Eugenio D Hottz
Journal:  Front Cell Infect Microbiol       Date:  2021-03-17       Impact factor: 5.293

7.  Hospitalization, mechanical ventilation, and case-fatality outcomes in US veterans with COVID-19 disease between years 2020-2021.

Authors:  Jessica Luo; Megan Rosales; Guo Wei; Gregory J Stoddard; Alvin C Kwok; Sujee Jeyapalina; Jayant P Agarwal
Journal:  Ann Epidemiol       Date:  2022-04-21       Impact factor: 6.996

8.  Dyslipidemia Increases the Risk of Severe COVID-19: A Systematic Review, Meta-analysis, and Meta-regression.

Authors:  Indriwanto Sakidjan Atmosudigdo; Raymond Pranata; Michael Anthonius Lim; Joshua Henrina; Emir Yonas; Rachel Vania; Basuni Radi
Journal:  J Clin Exp Hepatol       Date:  2021-02-08

9.  COVID-19 lockdown consequences on body mass index and perceived fragility related to physical activity: A worldwide cohort study.

Authors:  Constanta Urzeala; Martine Duclos; Ukadike Chris Ugbolue; Aura Bota; Mickael Berthon; Keri Kulik; David Thivel; Reza Bagheri; Yaodong Gu; Julien S Baker; Nicolas Andant; Bruno Pereira; Karine Rouffiac; Maëlys Clinchamps; Frédéric Dutheil
Journal:  Health Expect       Date:  2021-06-09       Impact factor: 3.318

10.  Substance Use, Mental Health, and Weight-Related Behaviors During the COVID-19 Pandemic Among Metabolic and Bariatric Surgery Patients.

Authors:  Sarah E Messiah; Maduri Uppuluri; Luyu Xie; Jeffrey N Schellinger; M Sunil Mathew; Ashley Ofori; Sachin Kukreja; Benjamin Schneider; Samuel H Dunn; Anna Tavakkoli; Jaime P Almandoz
Journal:  Obes Surg       Date:  2021-05-27       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.